Genetic progression and clonal relationship of recurrent premalignant head and neck lesions
- PMID: 10690509
Genetic progression and clonal relationship of recurrent premalignant head and neck lesions
Abstract
We constructed a preliminary genetic progression model for head and neck squamous cell carcinoma (HNSC) based on the frequency of genetic alterations in preneoplastic and neoplastic lesions from single biopsy specimens. To firmly establish the temporal order of established genetic events in HNSC, we sampled serial biopsies from five patients with recurrent premalignant lesions at a single anatomic site over a period of time (1 month to 144 months). These lesions were examined by microsatellite analysis of the minimal regions of loss on the 10 most frequently lost chromosomal arms in HNSC. Each set of serial biopsies from all five patients demonstrated LOH (loss of heterozygosity) of identical alleles at multiple loci with identical boundaries between areas of LOH and retention of heterozygosity, indicating a common clonal origin for each set. Three patients demonstrated genetic progression (new regions of LOH) over time correlating with histopathological progression, one patient demonstrated lack of genetic progression associated with unchanged histopathological morphology, and one patient demonstrated histopathological progression without detection of a corresponding genetic progression event. For one of these patients with a laryngeal tumor, at least four separate steps in progression to malignancy could be determined, accompanied by spatial expansion of an increasingly altered clonal population from the ipsilateral to the contralateral side, ultimately resulting in a malignancy. Microsatellite-based genetic analysis of recurrent premalignant lesions indicates that these lesions arise from a common clonal progenitor, followed by outgrowth of clonal populations associated with progressive genetic alterations and phenotypic progression to malignancy.
Similar articles
-
Allelic losses in OraTest-directed biopsies of patients with prior upper aerodigestive tract malignancy.Clin Cancer Res. 2001 Jul;7(7):1963-8. Clin Cancer Res. 2001. PMID: 11448911
-
Sequential loss of heterozygosity at microsatellite motifs in preinvasive and invasive head and neck squamous carcinoma.Cancer Res. 1995 Jun 15;55(12):2656-9. Cancer Res. 1995. PMID: 7780981
-
Use of allelic loss to predict malignant risk for low-grade oral epithelial dysplasia.Clin Cancer Res. 2000 Feb;6(2):357-62. Clin Cancer Res. 2000. PMID: 10690511
-
Advances in the diagnosis of oral premalignant and malignant lesions.J Can Dent Assoc. 2002 Nov;68(10):617-21. J Can Dent Assoc. 2002. PMID: 12410942 Review.
-
Detection of chromosome instability of tissue fields at risk: in situ hybridization.J Cell Biochem Suppl. 1996;25:57-62. J Cell Biochem Suppl. 1996. PMID: 9027599 Review.
Cited by
-
The Emerging Role of NANOG as an Early Cancer Risk Biomarker in Patients with Oral Potentially Malignant Disorders.J Clin Med. 2019 Sep 3;8(9):1376. doi: 10.3390/jcm8091376. J Clin Med. 2019. PMID: 31484317 Free PMC article.
-
The Genetic and Immunologic Landscape Underlying the Risk of Malignant Progression in Laryngeal Dysplasia.Cancers (Basel). 2023 Feb 9;15(4):1117. doi: 10.3390/cancers15041117. Cancers (Basel). 2023. PMID: 36831458 Free PMC article.
-
Genetic Changes Driving Immunosuppressive Microenvironments in Oral Premalignancy.Front Immunol. 2022 Jan 27;13:840923. doi: 10.3389/fimmu.2022.840923. eCollection 2022. Front Immunol. 2022. PMID: 35154165 Free PMC article. Review.
-
Development of tissue-engineered models of oral dysplasia and early invasive oral squamous cell carcinoma.Br J Cancer. 2011 Nov 8;105(10):1582-92. doi: 10.1038/bjc.2011.403. Epub 2011 Oct 11. Br J Cancer. 2011. PMID: 21989184 Free PMC article.
-
Cancer stem cells in head and neck cancer.Onco Targets Ther. 2012;5:375-83. doi: 10.2147/OTT.S38694. Epub 2012 Nov 21. Onco Targets Ther. 2012. PMID: 23189032 Free PMC article.
MeSH terms
LinkOut - more resources
Medical